Alibaba Health Information Technology Limited

HKSE 0241.HK

Alibaba Health Information Technology Limited Price to Earnings Ratio (P/E) on January 14, 2025: 55.23

Alibaba Health Information Technology Limited Price to Earnings Ratio (P/E) is 55.23 on January 14, 2025, a -37.51% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Alibaba Health Information Technology Limited 52-week high Price to Earnings Ratio (P/E) is 104.20 on October 02, 2024, which is 88.67% above the current Price to Earnings Ratio (P/E).
  • Alibaba Health Information Technology Limited 52-week low Price to Earnings Ratio (P/E) is 40.02 on April 19, 2024, which is -27.53% below the current Price to Earnings Ratio (P/E).
  • Alibaba Health Information Technology Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 60.55.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
HKSE: 0241.HK

Alibaba Health Information Technology Limited

CEO Mr. Difan Shen
IPO Date July 6, 1972
Location Hong Kong
Headquarters Tower One
Employees 1,435
Sector Health Care
Industries
Description

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, sexual health and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and TCM through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, Gaode, DingTalk, and Quark. In addition, it engages in the tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong.

Similar companies

9618.HK

JD.com, Inc.

USD 17.45

5.32%

6618.HK

JD Health International Inc.

USD 3.65

3.06%

3690.HK

Meituan

USD 18.52

5.00%

2269.HK

WuXi Biologics (Cayman) Inc.

USD 2.26

4.12%

StockViz Staff

January 15, 2025

Any question? Send us an email